Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps.

Noubouossie DF, Whelihan MF, Yu YB, Sparkenbaugh E, Pawlinski R, Monroe DM, Key NS.

Blood. 2017 Feb 23;129(8):1021-1029. doi: 10.1182/blood-2016-06-722298.

PMID:
27919911
2.

Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.

Antoniak S, Cardenas JC, Buczek LJ, Church FC, Mackman N, Pawlinski R.

Cardiology. 2016 Nov 24;136(4):258-268. [Epub ahead of print]

PMID:
27880950
3.

Platelet HMGB1: the venous clot coordinator.

Pawlinski R.

Blood. 2016 Nov 17;128(20):2376-2378. No abstract available.

PMID:
27856468
4.

Protective and detrimental effects of neuroectodermal cell-derived tissue factor in mouse models of stroke.

Wang S, Reeves B, Sparkenbaugh EM, Russell J, Soltys Z, Zhang H, Faber JE, Key NS, Kirchhofer D, Granger DN, Mackman N, Pawlinski R.

JCI Insight. 2016 Jul 21;1(11). pii: e86663.

5.

Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation.

Wang S, Reeves B, Pawlinski R.

Thromb Res. 2016 May;141 Suppl 2:S65-7. doi: 10.1016/S0049-3848(16)30369-3.

PMID:
27207429
6.

The design and synthesis of new synthetic low-molecular-weight heparins.

Chandarajoti K, Liu J, Pawlinski R.

J Thromb Haemost. 2016 Jun;14(6):1135-45. doi: 10.1111/jth.13312. Review.

PMID:
26990516
7.

Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice.

Antoniak S, Tatsumi K, Hisada Y, Milner JJ, Neidich SD, Shaver CM, Pawlinski R, Beck MA, Bastarache JA, Mackman N.

J Thromb Haemost. 2016 Jun;14(6):1238-48. doi: 10.1111/jth.13307. Erratum in: J Thromb Haemost. 2016 Dec;14 (12 ):2565.

PMID:
26947929
8.

Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease.

Sparkenbaugh EM, Chantrathammachart P, Chandarajoti K, Mackman N, Key NS, Pawlinski R.

Blood. 2016 Mar 10;127(10):1371-3. doi: 10.1182/blood-2015-11-681114. No abstract available.

PMID:
26817955
9.

In vitro and in vivo characterization of a reversible synthetic heparin analog.

Whelihan MF, Cooley B, Xu Y, Pawlinski R, Liu J, Key NS.

Thromb Res. 2016 Feb;138:121-9. doi: 10.1016/j.thromres.2015.12.007.

10.

It's "PT" for SCD!

Pawlinski R.

Blood. 2015 Oct 8;126(15):1739-40. doi: 10.1182/blood-2015-08-666594.

11.

Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury.

Rautou PE, Tatsumi K, Antoniak S, Owens AP 3rd, Sparkenbaugh E, Holle LA, Wolberg AS, Kopec AK, Pawlinski R, Luyendyk JP, Mackman N.

J Hepatol. 2016 Jan;64(1):53-9. doi: 10.1016/j.jhep.2015.08.017.

12.

Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2.

Maharshak N, Huh EY, Paiboonrungruang C, Shanahan M, Thurlow L, Herzog J, Djukic Z, Orlando R, Pawlinski R, Ellermann M, Borst L, Patel S, Dotan I, Sartor RB, Carroll IM.

Infect Immun. 2015 Jul;83(7):2762-70. doi: 10.1128/IAI.00425-15.

13.

Excess of heme induces tissue factor-dependent activation of coagulation in mice.

Sparkenbaugh EM, Chantrathammachart P, Wang S, Jonas W, Kirchhofer D, Gailani D, Gruber A, Kasthuri R, Key NS, Mackman N, Pawlinski R.

Haematologica. 2015 Mar;100(3):308-14. doi: 10.3324/haematol.2014.114728.

14.

The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.

Magnus N, Meehan B, Garnier D, Hashemi M, Montermini L, Lee TH, Milsom C, Pawlinski R, Ohlfest J, Anderson M, Mackman N, Rak J.

Biochem Biophys Res Commun. 2014 Nov 14;454(2):262-8.

PMID:
25450387
15.

Tissue factor, protease activated receptors and pathologic heart remodelling.

Antoniak S, Sparkenbaugh E, Pawlinski R.

Thromb Haemost. 2014 Nov;112(5):893-900. doi: 10.1160/TH14-03-0243. Review.

16.

Hemostasis: old system, new players, new directions.

Hoffman M, Pawlinski R.

Thromb Res. 2014 May;133 Suppl 1:S1-2. doi: 10.1016/j.thromres.2014.03.001.

PMID:
24759130
17.

De novo synthesis of a narrow size distribution low-molecular-weight heparin.

Chandarajoti K, Xu Y, Sparkenbaugh E, Key NS, Pawlinski R, Liu J.

Glycobiology. 2014 May;24(5):476-86. doi: 10.1093/glycob/cwu016.

18.

Homogeneous low-molecular-weight heparins with reversible anticoagulant activity.

Xu Y, Cai C, Chandarajoti K, Hsieh PH, Li L, Pham TQ, Sparkenbaugh EM, Sheng J, Key NS, Pawlinski R, Harris EN, Linhardt RJ, Liu J.

Nat Chem Biol. 2014 Apr;10(4):248-50. doi: 10.1038/nchembio.1459.

19.

Inhibit the calpain to climb the mountain.

Pawlinski R.

Blood. 2014 Feb 20;123(8):1123-4. doi: 10.1182/blood-2013-12-543397. No abstract available.

20.

Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations.

Magnus N, Garnier D, Meehan B, McGraw S, Lee TH, Caron M, Bourque G, Milsom C, Jabado N, Trasler J, Pawlinski R, Mackman N, Rak J.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3544-9. doi: 10.1073/pnas.1314118111.

Items per page

Supplemental Content

Loading ...
Support Center